FDA.reportPublic FDA data

Fluzone 2026 Southern Hemisphere vaccine Injectable Suspension

RxCUI
2738142
RxNorm name
Fluzone 2026 Southern Hemisphere vaccine Injectable Suspension
Display name
Fluzone 2026 Southern Hemisphere vaccine Injectable Suspension
Full name
Fluzone 2026 Southern Hemisphere vaccine Injectable Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103914Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone QuadrivalentInfluenza Virus Vaccine351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ced9a8b6-ef2c-a620-c61c-ff9374249543Fluzone 2026 Southern Hemisphere vaccine Injectable Suspension [PSN] · influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2026 Southern Hemisphere] [SBD] · Fluzone 2026 Southern Hemisphere vaccine Injectable Suspension [SY]38These highlights do not include all the information needed to use Fluzone ® Southern Hemisphere safely and effectively. See full prescribing information for Fluzone Southern Hemisphere. Fluzone (Influenza Vaccine) injectable suspension, for intramuscular use 2026 Formula Initial U.S. Approval: 198020260430